• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Lilly invests further $5.3 bln in new Indiana site as obesity drug demand soars

cafead

Administrator
Staff member
  • cafead   May 24, 2024 at 11:32: AM
via Eli Lilly (LLY.N) said on Friday it has invested another $5.3 billion in its new Lebanon, Indiana manufacturing plant, more than doubling its previous investment, as it scrambles to meet soaring demand for its weight-loss and diabetes drugs.

article source
 

<